JP2015516155A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015516155A5 JP2015516155A5 JP2015508975A JP2015508975A JP2015516155A5 JP 2015516155 A5 JP2015516155 A5 JP 2015516155A5 JP 2015508975 A JP2015508975 A JP 2015508975A JP 2015508975 A JP2015508975 A JP 2015508975A JP 2015516155 A5 JP2015516155 A5 JP 2015516155A5
- Authority
- JP
- Japan
- Prior art keywords
- expression
- cancer
- gene
- combination
- thy1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261639407P | 2012-04-27 | 2012-04-27 | |
| US61/639,407 | 2012-04-27 | ||
| PCT/US2013/032677 WO2013162776A1 (en) | 2012-04-27 | 2013-03-15 | Breast cancer prognosis, prediction of progesterone receptor subtype and|prediction of response to antiprogestin treatment based on gene expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015516155A JP2015516155A (ja) | 2015-06-11 |
| JP2015516155A5 true JP2015516155A5 (https=) | 2016-05-12 |
Family
ID=48045769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015508975A Pending JP2015516155A (ja) | 2012-04-27 | 2013-03-15 | 乳がん予後判定、プロゲステロン受容体サブタイプの予測および遺伝子発現に基づく抗プロゲスチン処置に対する応答の予測 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10501800B2 (https=) |
| EP (1) | EP2841594A1 (https=) |
| JP (1) | JP2015516155A (https=) |
| KR (1) | KR20150028232A (https=) |
| AU (1) | AU2013252913A1 (https=) |
| CA (1) | CA2871590A1 (https=) |
| HK (1) | HK1208057A1 (https=) |
| IL (1) | IL235351A0 (https=) |
| MX (1) | MX2014013044A (https=) |
| NZ (1) | NZ701652A (https=) |
| PH (1) | PH12014502410A1 (https=) |
| RU (1) | RU2014147625A (https=) |
| WO (1) | WO2013162776A1 (https=) |
| ZA (1) | ZA201407853B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2014013044A (es) | 2012-04-27 | 2015-06-23 | Univ Minnesota | Pronostico de cancer de mamas, prediccion de subtipo de receptor de progesterona y prediccion de respuesta a tratamiento de antiprogestina basado en la expresion de genes. |
| US20140363425A1 (en) * | 2013-03-13 | 2014-12-11 | J. Dinny Graham | Systems and methods for identifying cancers having activated progesterone receptors |
| US20150276767A1 (en) * | 2014-03-12 | 2015-10-01 | The University Of Sydney | Systems and methods for identifying cancers having activated progesterone receptors |
| CN113559075A (zh) | 2014-11-17 | 2021-10-29 | 康泰科思特生物制药公司 | 奥那司酮延长释放组合物和方法 |
| AU2016326657B2 (en) | 2015-09-25 | 2019-10-24 | Context Biopharma, Inc. | Methods of making onapristone intermediates |
| EP3389632A4 (en) | 2015-12-15 | 2019-11-06 | Context Biopharma Inc. | AMORPHIC ONAPRISTON COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF |
| WO2018102369A1 (en) | 2016-11-30 | 2018-06-07 | Arno Therapeutics, Inc. | Methods for onapristone synthesis dehydration and deprotection |
| US10942183B2 (en) | 2017-04-05 | 2021-03-09 | Regents Of The University Of Minnesota | Methods of detecting progesterone receptor and of detecting an expression level |
| EP3822368A1 (en) | 2019-11-14 | 2021-05-19 | Koninklijke Philips N.V. | Assessment of pr cellular signaling pathway activity using mathematical modelling of target gene expression |
| EP4121964A1 (en) * | 2020-03-17 | 2023-01-25 | Regeneron Pharmaceuticals, Inc. | Methods and systems for determining responders to treatment |
| JP7619556B2 (ja) * | 2020-10-08 | 2025-01-22 | 藤倉化成株式会社 | 動脈病変を検出し、並びに、脳心臓血管障害、糖尿病、慢性腎臓病、又は固形癌を検出する、体液抗体バイオマーカー |
| US20250005743A1 (en) * | 2023-06-30 | 2025-01-02 | Mackay Memorial Hospital | Method and system for identifying hormone receptor status |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6750015B2 (en) * | 2000-06-28 | 2004-06-15 | Kathryn B. Horwitz | Progesterone receptor-regulated gene expression and methods related thereto |
| AU2001271579A1 (en) | 2000-06-28 | 2002-01-08 | University Technology Corporation | Progesterone receptor-regulated gene expression and methods related thereto |
| MX2014013044A (es) | 2012-04-27 | 2015-06-23 | Univ Minnesota | Pronostico de cancer de mamas, prediccion de subtipo de receptor de progesterona y prediccion de respuesta a tratamiento de antiprogestina basado en la expresion de genes. |
-
2013
- 2013-03-15 MX MX2014013044A patent/MX2014013044A/es unknown
- 2013-03-15 KR KR20147033298A patent/KR20150028232A/ko not_active Withdrawn
- 2013-03-15 HK HK15108666.9A patent/HK1208057A1/xx unknown
- 2013-03-15 US US13/843,482 patent/US10501800B2/en active Active
- 2013-03-15 WO PCT/US2013/032677 patent/WO2013162776A1/en not_active Ceased
- 2013-03-15 EP EP13714144.6A patent/EP2841594A1/en not_active Withdrawn
- 2013-03-15 AU AU2013252913A patent/AU2013252913A1/en not_active Abandoned
- 2013-03-15 CA CA2871590A patent/CA2871590A1/en not_active Abandoned
- 2013-03-15 RU RU2014147625A patent/RU2014147625A/ru not_active Application Discontinuation
- 2013-03-15 NZ NZ701652A patent/NZ701652A/en not_active IP Right Cessation
- 2013-03-15 JP JP2015508975A patent/JP2015516155A/ja active Pending
-
2014
- 2014-10-27 IL IL235351A patent/IL235351A0/en unknown
- 2014-10-27 PH PH12014502410A patent/PH12014502410A1/en unknown
- 2014-10-28 ZA ZA2014/07853A patent/ZA201407853B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015516155A5 (https=) | ||
| RU2014147625A (ru) | Прогнозирование рака молочной железы, предсказание подтипа прогестероновых рецепторов и предсказание ответа на лечение антипрогестином на основании генной экспрессии | |
| Teixeira et al. | Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients | |
| JP2013500001A5 (https=) | ||
| Starnawska et al. | Blood DNA methylation age is not associated with cognitive functioning in middle-aged monozygotic twins | |
| Riveiro-Falkenbach et al. | Intra-and inter-tumoral homogeneity of BRAFV600E mutations in melanoma tumors | |
| RU2014120427A (ru) | Определение микрорнк в плазме для обнаружения ранних стадий колоректального рака | |
| JP2010539508A5 (https=) | ||
| Huerta et al. | Role of p53, Bax, p21, and DNA-PKcs in radiation sensitivity of HCT-116 cells and xenografts | |
| KR20160061424A (ko) | 유방암으로부터 기원하는 골의 전이성 암의 예후 및 치료 방법 | |
| CN106148529A (zh) | 与胃癌相关的LncRNA标记物及其专用检测引物、检测方法、试剂盒与应用 | |
| CN101792793B (zh) | miR-182作为胶质瘤发生分子标志物的应用及其检测试剂盒 | |
| Puente et al. | Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma | |
| Li et al. | The prognostic value of COX-2 expression on circulating tumor cells in nasopharyngeal carcinoma: a prospective analysis | |
| Yang et al. | The diagnostic value and prospects of gene mutations in circulating tumor DNA for head and neck cancer monitoring | |
| Fjeldheim et al. | Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes. | |
| KR102216725B1 (ko) | 면역 항암 요법에 대한 치료 반응 예측 방법 | |
| CN103205423A (zh) | 一种前列腺癌生物标志物miR-126-5P、诊断试剂盒及应用 | |
| CN105624271A (zh) | 一种与结直肠癌相关的miRNA及其应用 | |
| Rokhzadi et al. | Advancements in Emerging Molecular Approaches: Promising Diagnostic and Therapies Methods for Triple-Negative Breast Cancer (TNBC) Treatment | |
| Wang et al. | Differentially expressed gene profiles in the serum before and after the ultrasound-guided ethanol sclerotherapy in patients with ovarian endometriomas | |
| JP5897823B2 (ja) | 膀胱ガン診断用組成物及び方法 | |
| WO2014124267A1 (en) | Method for diagnosis, prognosis and determination of treatment for cutaneous t-cell lymphoma | |
| Ding et al. | rs621554 single nucleotide polymorphism of DLC1 is associated with breast cancer susceptibility and prognosis | |
| Serilmez et al. | CAN LYVE-1 MOLECULE BE A DIAGNOSTIC BIOMARKER IN PATIENTS WITH ADVANCED LUNG CANCER? |